3D Graphene BioFET Fabrication for High-Salt Analyte Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional biological field-effect transistors (BioFETs) face challenges in detecting analytes in high salt concentration environments due to ionic screening effects and limited sensitivity, which hinders their application in medical diagnostics and point-of-care diagnostics.

Innovation Solution

The use of a three-dimensional (3D) graphene layer in BioFETs, which is biofunctionalized with molecular recognition elements, enhances sensitivity by modulating the Debye length and providing a larger exposed surface area for analyte binding, allowing for selective detection of analytes in high salt concentrations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional 2D graphene-based BioFETs are used, then the device structure is simple and fabrication is easier, but the sensitivity is limited and ionic screening effects occur in high salt concentration environments

Engineering Contradiction:
Improveanalyte detection sensitivityVSAvoidgraphene layer structure
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent transitions from conventional 2D graphene layers to vertically-aligned 3D graphene structures. This dimensional change increases the exposed surface area for analyte binding sites while maintaining compatibility with standard semiconductor fabrication processes. The vertical alignment provides greater surface area exposure to the analyte environment, thereby enhancing sensitivity and reducing ionic screening effects in high salt concentration conditions.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Adaptability or versatility

If the graphene layer is biofunctionalized with molecular recognition elements, then the selectivity for specific analytes is improved, but the fabrication process becomes more complex

Engineering Contradiction:
Improveanalyte selectivityVSAvoidfabrication process
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent applies biofunctionalization techniques to the vertically-aligned 3D graphene structure after it has been deposited and patterned. Molecular recognition elements are attached to the graphene surface in advance of the actual sensing application, allowing the structure to be pre-prepared with specific binding capabilities. This preliminary functionalization integrates seamlessly with standard semiconductor fabrication workflows, adding selectivity without requiring fundamentally new manufacturing processes.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If the exposed surface area of graphene is increased for better analyte binding, then the sensitivity is improved, but the device complexity increases

Engineering Contradiction:
Improveanalyte detection sensitivityVSAvoidgraphene layer configuration
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent employs vertically-aligned 3D graphene structures that exhibit curved and folded configurations rather than flat 2D sheets. This curvature and vertical orientation naturally increase the exposed surface area without requiring complex multi-layer stacking or irregular geometries. The vertically-aligned structure achieves enhanced surface area-to-volume ratio through controlled growth and alignment, improving analyte binding capacity while maintaining fabrication simplicity.

Inventive Principle:
Principle #14Spheroidality (Curvature)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The 3D graphene-based BioFETs demonstrate improved sensitivity and selectivity in detecting analytes at physiologically relevant salt concentrations, overcoming the limitations of 2D graphene-based BioFETs by reducing ionic screening effects and enabling accurate detection in complex mixtures like serum or bodily fluids.

Implementation Method 1

enhances sensitivity by modulating the Debye length and providing a larger exposed surface area for analyte binding

Methodology Applied
Scientific EffectDebye length modulation: Debye-Falkenhagen Effect

Implementation Method 2

biofunctionalizing the carbonaceous dispersion with a molecular recognition element configured to alter one or more electrical properties of the Bio-FET in response to exposure of the molecular recognition element to the analyte

Methodology Applied
Scientific EffectMolecular recognition: Adsorption

Data Source

PatentUS11988629B2Method of manufacturing a graphene-based biological field-effect transistor
Publication Date: 2024.05.21 LYTEN INC
  • US11988629B2 patent drawing
  • US11988629B2 patent drawing
  • US11988629B2 patent drawing

AI summary

A method for manufacturing a biological field-effect transistor (BioFET) is disclosed. In some implementations, the method may include preparing a carbonaceous dispersion by adding a three-dimensional (3D) graphene into a solvent; depositing the carbonaceous dispersion onto a p-type silicon wafer; spin-coating a positive photoresist over the carbonaceous dispersion; forming source and drain terminals on the p-type silicon wafer, the source and drain terminals in contact with the 3D graphene of the carbonaceous dispersion; removing residual photoresist from the carbonaceous dispersion by placing the p-type silicon wafer in 1-methyl-2-pyrrolidone (NMP); and biofunctionalizing the carbonaceous dispersion with a molecular recognition element configured to alter one or more electrical properties of the Bio-FET in response to exposure of the molecular recognition element to the analyte.